Minesse (Ethinylestradiol, Gestodene | Lactose Monohydrate)

Minesse is a combined oral contraceptive that acts on the hormonal regulation of the menstrual cycle to prevent pregnancy.

• Contraception: provides reliable prevention of pregnancy in women of child‑bearing potential.
• Menstrual cycle regulation: helps achieve more predictable and lighter periods.
• Acne management: may improve acne associated with hormonal fluctuations.

• Minesse combines ethinylestradiol, a synthetic estrogen, with gestodene, a progestogen. The estrogen suppresses the mid‑cycle surge of luteinizing hormone, while the progestogen inhibits follicle‑stimulating hormone release, together preventing ovulation. Additionally, the formulation thickens cervical mucus and alters the endometrium, reducing the likelihood of fertilisation and implantation.

Minesse may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Breast tenderness: discomfort or swelling of the breasts.
• Headache: occasional mild to moderate pain.
• Spotting or breakthrough bleeding: irregular light bleeding.
• Mood changes: fluctuations in emotional state.
• Weight gain: slight increase in body weight.

Serious or Rare Side Effects

• Deep vein thrombosis: blood clot formation in deep veins.
• Pulmonary embolism: clot migration to lung arteries.
• Stroke: interruption of cerebral blood flow.
• Myocardial infarction: heart attack due to blocked coronary arteries.
• Severe allergic reaction: rash, swelling, or anaphylaxis.
• Liver dysfunction: jaundice or abnormal liver enzymes.

Before prescribing Minesse, clinicians should evaluate patient risk factors and contraindications.

• Assess thrombotic risk: review history of clotting disorders or recent surgery.
• Screen for hypertension: ensure blood pressure is controlled.
• Avoid smoking: especially in women over 35 years of age.
• Consider liver function: monitor in patients with hepatic impairment.
• Contraindicated in pregnancy: do not use if the patient is pregnant.
• Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

Minesse can interact with several medications that affect hormone metabolism or clotting risk.

Major Interactions (Avoid)

• Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): may markedly reduce contraceptive efficacy.
• Rifampicin: decreases plasma hormone levels, compromising birth control.
• Certain antiretrovirals (e.g., efavirenz): may lower effectiveness of the oral contraceptive.

Moderate Interactions (Monitor Closely)

• Broad‑spectrum antibiotics (e.g., ampicillin): may slightly reduce contraceptive effect.
• Herbal supplements (e.g., St. John's wort): can decrease hormone concentrations.
• Antifungals (e.g., fluconazole): may increase hormone levels, raising side‑effect risk.